Advertisement

Topics

Companies Related to "Cara Therapeutics Present November Investor Conferences" [Most Relevant Company Matches] RSS

15:36 EDT 18th September 2018 | BioPortfolio

Here are the most relevant search results for "Cara Therapeutics Present November Investor Conferences" found in our extensive corporate database of over 50,000 company records.

Showing "Cara Therapeutics Present November Investor Conferences" Companies 1–25 of 2,500+

Extremely Relevant

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has entered clinical testing for acute pain. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to...


Relevant

Cara Therapeutics, Inc.

CARA THERAPEUTICS -- OU NAME


LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations....

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. (CAPR), a publicly traded biotechnology company, is focused on the development of novel therapeutics to prevent and treat heart disease. The Company was formed through the November 2013 merger between Capricor, Inc., a privately held company whose mission is to improve the treatment of heart disease by commercializing cardiac st...

Pharmaceutical Executive Conferences website

Welcome to the Pharmaceutical Executive Conferences website Pharmaceutical Executive Conferences provide top industry gatherings for up-to-the-minute information and unmatched opportunity to interact with other pharmaceutical industry executives. Every Pharmaceutical Executive Conference offers rich content presented in an opportune setting for the exchange of ideas and solutions to today’s indu...

Messe Frankfurt GmbH

Within the German Equity Forum Fall 2006 more than 200 listed companies will hold their analyst conference and will present their 3rd quarter results to analysts and institutional investors. The presentations are hosted and moderated by experts of our Main Sponsors.The timetable of the analyst conferences can be found here

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC

Heartland Advisors, Inc.

Heartland Advisors, Inc. is an independently owned Milwaukee-based firm established in 1983 and renowned as America’s Value Investor®. As of May 31, 2012, the firm managed approximately $4.9 billion for institutional and high net worth clients and the Heartland family of value-driven mutual funds, which include the Heartland Value Fund (Investor: HRTVX), ...

Profile Therapeutics plc

In 1994, the business was acquired by its management in order to progress the development of its innovative platform "intelligent inhalation" technology known as Adaptive Aerosol Delivery™ or "AAD™". In March 2000, Profile Therapeutics plc completed its IPO on the London Stock Exchange to exploit the opportunities presented by this technology. Profile Therapeutics plc now comprises three compl...

International Business Forum, Inc.

IBF*International Business Forum, Inc. is a leading presenter of venture capital, technology innovation and private equity conferences in the United States. For 20 years, IBF has been presenting conferences which unite investors, emerging growth companies and corporations. IBF produces conferences on the following venture capital subjects: Venture Capital Investing, Early Stage Investing, Cleantec...

Health Policy Resources

The Health Policy Resources Group, LLC is dedicated to helping clients improve the delivery and quality of health and mental health services. Our expertise is reflected in numerous publications, frequent presentations at conferences and other meetings, and in former and present positions of national leadership. We invite you to become acquainted.

Bio/Med Investor Network

The Bio/Med Investor Network was formed in 2014 to address the need for funding in early-stage bioscience and healthcare companies. Network members are accredited angel investors specializing in these fields to provide a high level of scrutiny and guidance for growing companies. The Network is based in Atlanta, Georgia with about 40 investor/members. More ...

Cambridge Healthtech Institute

CHI’s renowned conferences are the underpinning for all our other information resources. Each year, approximately 85 conferences are held throughout the US and Europe. Conference programs are designed to be a useful, timely, and effective supplement to specialized journals, newsletters, and other meetings. We strive to develop quality programs that provide valuable new insights and competing poi...

Investor Protection Trust, Investor Protection Institute and National Adult Protective Services Association

Owicki Consulting

Prior to becoming a consultant in 1999, I held technical and executive corporate positions (e.g., V.P. of Research at LJL BioSystems, Inc.) and an academic post (Assoc. Prof. of Biophysics, U.C. Berkeley). Other professional activities include membership on several journal editorial boards, organizing sessions at conferences, and speaking at conferences.

Jounce Therapeutics

Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to driv...

Jounce Therapeutics, Inc.

Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing novel cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to drive signifi...

First Conferences

Launched in June 1990 in London, First Conferences Ltd [FC] quickly grew to become a significant player in the global events market.Our policy of encouraging entrepreneurship and offering high levels of employee autonomy quickly attracted a dynamic team able to work effectively in any market, in any industry and on any opportunity

Scivent

SCIVENT is your competent partner for the planning, organization, and realization of conferences business meetings round table discussions lecture series product introductions employee or customer trainingWith SCIVENT, you can concentrate completely on your most important tasks. Scivent develops and markets your ideas and concepts for new conferences and events.

Irish BioIndustry Association

BioIreland 2006 - Inspire, Invest, Innovate is the third in a series of conferences profiling the Island of Ireland as a location of choice for the development of the biotech sector. Over the past ten years we have seen Ireland develop and grow into a serious biotech player and it is important that we continue in this fashion.BioIreland 2006 will therefore examine global trends in biotechnology as...

Michael Murphy's New World Investor

This is a solicitation for Michael Murphy's New World Investor, a weekly general interest newsletter which is not liable for the suitability or future investment performance of any securities or strategies discussed. Historical investment return examples given are hypothetical, and not to be taken as representative of any individual's actual trading experience. For access to our full disclaimer an...

GlycoVaxyn AG

GlycoVaxyn is a Zurich based biotechnology company. It was incorporated in November 2004 as a spin-off company of the ETH Zurich. Michael WackerMichael Wacker is a graduate in Biochemistry of the ETH in Zürich. Together with Prof. M. Aebi (Institute of Microbiology of the Swiss Federal Institute of Technology, ETH), he is the inventor of GlycoVaxyn’s technology, which he developed during his Ph...

Developmentr institute international

Dii was established in 1993 with the objective of providing the best quality of information conferences and trainings to business executives in France. In less than 15 years, most of Dii's annual conferences have become the "must attend" event for its industry. Thanks to its dynamic, client driven and efficient team, Dii has been successful to respond to the specific needs of the Franco-phone mark...

Reddy US Therapeutics, Inc

Reddy US Therapeutics, Inc., part of Dr. Reddy's Discovery Research, was established in November 1999. Our company is located in the wooded suburbs of Atlanta. We currently occupy over 25000 sq. ft. of a state-of-the-art laboratory facility that is designed and equipped for molecular biological, biochemical and chemical research.Our company has been a subsidiary of Dr. Reddy's Laboratories Limited...


More From BioPortfolio on "Cara Therapeutics Present November Investor Conferences"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks